肝臟癌症診斷的全球市場預測(到2028年):COVID-19影響,各類型,終端用戶別分析
市場調查報告書
商品編碼
1070730

肝臟癌症診斷的全球市場預測(到2028年):COVID-19影響,各類型,終端用戶別分析

Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and End User

出版日期: | 出版商: The Insight Partners | 英文 181 Pages | 訂單完成後即時交付

價格

全球肝臟癌症診斷的市場規模在2021年估算為93億2,314萬美金,2021年~2028年間預測將以8.0%的年複合成長率增長,2028年前達到159億5,177萬美元。

這份報告提供全球肝臟癌症診斷市場調查,提供市場概要,市場的推動因素與阻礙因素的分析,市場機會,COVID-19影響,各市場區隔的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

第2章 肝臟癌症診斷市場:重要的要點

第3章 調查手法

第4章 肝臟癌症診斷市場:市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 肝臟癌症診斷市場:主要的市場動態

  • 市場促進因素
  • 市場阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 肝臟癌症診斷:全球市場分析

  • 世界市場收益預測與分析
  • 各地區的全球市場的預測與分析
  • 主要企業的市場定位

第7章 肝臟癌症診斷市場分析:各類型

  • 概要
  • 各類型的市場收益佔有率(2021年及2028年)
  • 實驗室實驗
  • 內視鏡檢驗
  • 成像
  • 切片檢查
  • 其他

第8章 肝臟癌症診斷市場分析:各終端用戶

  • 概要
  • 各終端用戶的市場收益佔有率(2021年及2028年)
  • 醫院及診斷研究所
  • 學術調查
  • CRO檢驗所

第9章 肝臟癌症診斷市場收益與2028年為止的預測:地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第10章 COVID-19對肝臟癌症診斷市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第11章 肝臟癌症診斷市場:產業形勢的展望

  • 概要
  • 市場上成長策略
  • 有機的開發
  • 無機的開發

第12章 企業簡介

  • Abbott
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • QIAGEN
  • Siemens Healthineers AG
  • THERMO FISHER SCIENTIFIC INC.
  • GE Healthcare
  • Perspectum
  • Helio, Inc

第13章 附錄

  • The Insight Partners
  • 詞彙表
Product Code: TIPRE00003017

The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021-2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the liver cancer diagnostics market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.

Hepatocellular carcinoma is the most frequent type of liver; it starts in the major type of liver cell (hepatocyte) and is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Further, other kinds of liver cancer are significantly less prevalent, such as intrahepatic cholangiocarcinoma and hepatoblastoma. Cancer that begins in another area of the body, such as the colon, lung, or breast, and then spreads to the liver is called metastatic cancer. Moreover, metastatic colon cancer is a kind of cancer that starts in the colon and spreads to the liver. For instance, according to CDC (Centers of Disease Control and Prevention), each year in the US, about 24,500 men and 10,000 women get liver cancer, and about 18,600 men and 9,000 women die from the disease. The percentage of Americans who get liver cancer has been rising for several decades. Liver cancer is more common in other parts of the world than in the US. Moreover, according to an article published in CCO (Chinese Clinical Oncology), hepatocellular cancer (HCC) is a leading cause of cancer death worldwide. In Europe, HCC accounts for around 47,000 deaths per year. The incidence is comparatively low except in Southern Europe, where the age-standardized incidence rate in men is 9.8 per 100,000 compared with 3.8 in Northern Europe, 4.6 in central and Eastern Europe, and 7.2 in Western Europe. However, in the UK, mortality rates from HCC are expected to rise by 14% between 2006 and 2025 representing the largest increase in any male cancer. Furthermore, being overweight or having obesity is a risk factor for liver cancer and non-alcoholic fatty liver disease is a common condition in obese people. People with a subtype of non-alcoholic fatty liver disease, known as non-alcoholic steatohepatitis (NASH), might develop cirrhosis, which can cause liver cancer. According to a research article by Eunsun Kim et al., published in Experimental & Molecular Medicine Journal 2020, the incidence rate associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing, and the global burden of mortality from hepatocellular carcinoma (HCC) is predicted to reach 1 million deaths annually by 2030. In addition, certain inherited metabolic diseases can lead to cirrhosis. Lifestyle and behaviors such as smoking cigarettes and drinking alcohol are the leading cause of cirrhosis in the US, which is linked with an increased risk of liver cancer. Further, Type 2 diabetes has been linked with an increased risk of liver cancer, usually in patients with other risk factors such as heavy alcohol use or chronic viral hepatitis. This risk may also be increased as people with type 2 diabetes tend to be overweight or obese, which, in turn, can cause liver problems. According to IDF Diabetes Atlas Tenth edition 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The factors mentioned above are increasing the chances of liver cancer, thereby driving the liver cancer diagnostics market.

The global liver cancer diagnostics market, based on type, is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The market for the laboratory tests segment is further segmented into blood tests and biomarkers. The laboratory tests segment held the largest share of the market in 2021. However, the imaging segment is anticipated to register a CAGR of 8.5% in the market during the forecast period. Based on end user, the global liver cancer diagnostics market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. The hospitals and diagnostic laboratories segment held the largest share of the market in 2021 as the hospitals provide healthcare facilities through specialized scientific equipment. A team of trained staff is assigned to deal, investigate, and restore the problems associated with modern medical science in the hospital. Various medical research teams are constantly working on introducing innovative technologies related to the diagnostics methods and other activities in the medical field. The patients generally prefer the hospital to take liver cancer treatment due to the availability of advanced treatment options. The hospitals are the point of care for the patients. Moreover, the same segment is anticipated to register a CAGR of 8.5% in the market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the liver cancer diagnostics market are the National Center for Health Statistics; Centers for Disease Control and Prevention (CDC); National Institute of Statistics, Geography, and Informatics; National Health and Medical Research Council; and World Health Organization.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global liver cancer diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global liver cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Liver Cancer Diagnostics Market - By Type
    • 1.3.2 Global Liver Cancer Diagnostics Market - By End User
    • 1.3.3 Global Liver Cancer Diagnostics Market - By Geography

2. Liver Cancer Diagnostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Liver Cancer Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion

5. Liver Cancer Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Liver Cancer
    • 5.1.2 Rising R&D Investments for the Development of Novel Diagnostic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Demand for Point-of-Care Testing
  • 5.4 Future Trends
    • 5.4.1 Rising Emergence of New Technologies
  • 5.5 Impact Analysis

6. Liver Cancer Diagnostics Market - Global Analysis

  • 6.1 Global Liver Cancer Diagnostics Market Revenue Forecast and Analysis
  • 6.2 Global Liver Cancer Diagnostics Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Liver Cancer Diagnostics Market Analysis - By Type

  • 7.1 Overview
  • 7.2 Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
  • 7.3 Laboratory Tests
    • 7.3.1 Overview
    • 7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Blood Tests
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.2 Biomarkers
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Endoscopy
    • 7.4.1 Overview
    • 7.4.2 Endoscopy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Imaging
    • 7.5.1 Overview
    • 7.5.2 Imaging: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Biopsy
    • 7.6.1 Overview
    • 7.6.2 Biopsy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. Liver Cancer Diagnostics Market Analysis - By End User

  • 8.1 Overview
  • 8.2 Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
  • 8.3 Hospitals and Diagnostics Laboratories
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Academic and Research Institutes
    • 8.4.1 Overview
    • 8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 CRO Laboratories
    • 8.5.1 Overview
    • 8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 9.1 North America: Liver Cancer Diagnostics Market
    • 9.1.1 Overview
    • 9.1.2 North America Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 9.1.3 North America Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
      • 9.1.3.1 North America Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
    • 9.1.4 North America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
    • 9.1.5 North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
      • 9.1.5.1 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.1.1 Overview
        • 9.1.5.1.2 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.1.3 US Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.1.3.1 US Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.1.4 US Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
      • 9.1.5.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.2.1 Overview
        • 9.1.5.2.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.2.3 Canada Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.2.3.1 Canada Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.2.4 Canada Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
      • 9.1.5.3 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.3.1 Overview
        • 9.1.5.3.2 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.3.3 Mexico Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.3.3.1 Mexico Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.1.5.3.4 Mexico Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • 9.2 Europe: Liver Cancer Diagnostics Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
    • 9.2.3 Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
      • 9.2.3.1 Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
    • 9.2.4 Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
    • 9.2.5 Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
      • 9.2.5.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.1.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.1.2 Germany: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.1.2.1 Germany: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.1.3 Germany: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 9.2.5.2 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.2.1 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.2.2 UK: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.2.2.1 UK: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.2.3 UK: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 9.2.5.3 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.3.1 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.3.2 France: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.3.2.1 France: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.3.3 France: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 9.2.5.4 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.4.1 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.4.2 Spain: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.4.2.1 Spain: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.4.3 Spain: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 9.2.5.5 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.5.1 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.5.2 Italy: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.5.2.1 Italy: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.5.3 Italy: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 9.2.5.6 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.6.1 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
        • 9.2.5.6.2 Rest of Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
        • 9.2.5.6.2.1 Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
        • 9.2.5.6.3 Rest of Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
  • 9.3 Asia-Pacific: Liver Cancer Diagnostics Market
    • 9.3.1 Overview
    • 9.3.2 Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.3.3 Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
      • 9.3.3.1 Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
    • 9.3.4 Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
    • 9.3.5 Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
      • 9.3.5.1 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.1 Overview
        • 9.3.5.1.2 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.3 China: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.1.3.1 China: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
        • 9.3.5.1.4 China: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
      • 9.3.5.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.1 Overview
        • 9.3.5.2.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.3 Japan: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.2.3.1 Japan: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
        • 9.3.5.2.4 Japan: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
      • 9.3.5.3 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.1 Overview
        • 9.3.5.3.2 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.3 India: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.3.3.1 India: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
        • 9.3.5.3.4 India: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
      • 9.3.5.4 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.1 Overview
        • 9.3.5.4.2 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.3 South Korea: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.4.3.1 South Korea: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
        • 9.3.5.4.4 South Korea: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
      • 9.3.5.5 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.1 Overview
        • 9.3.5.5.2 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.3 Australia: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.5.3.1 Australia: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
        • 9.3.5.5.4 Australia: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
      • 9.3.5.6 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Overview
        • 9.3.5.6.2 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.3 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
        • 9.3.5.6.3.1 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
        • 9.3.5.6.4 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
  • 9.4 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
      • 9.4.3.1 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
    • 9.4.4 Middle East & Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
    • 9.4.5 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 9.4.5.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.1.1 Overview
        • 9.4.5.1.2 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.1.3 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 9.4.5.1.3.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
        • 9.4.5.1.4 UAE: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
      • 9.4.5.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.2.1 Overview
        • 9.4.5.2.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.2.3 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 9.4.5.2.3.1 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
        • 9.4.5.2.4 Saudi Arabia: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
      • 9.4.5.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.3.1 Overview
        • 9.4.5.3.2 South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.3.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 9.4.5.3.3.1 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
        • 9.4.5.3.4 South Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
      • 9.4.5.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 9.4.5.4.3.1 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
        • 9.4.5.4.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 South and Central America Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 9.5.3 South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
      • 9.5.3.1 South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
    • 9.5.4 South and Central America: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
    • 9.5.5 South and Central America: Liver Cancer Diagnostics Market Share by Country - 2021 & 2028, (%)
      • 9.5.5.1 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
        • 9.5.5.1.1 Overview
        • 9.5.5.1.2 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
        • 9.5.5.1.3 Brazil Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.1.3.1 Brazil Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.1.4 Brazil Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
        • 9.5.5.2.1 Overview
        • 9.5.5.2.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
        • 9.5.5.2.3 Argentina Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.2.3.1 Argentina Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.2.4 Argentina Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.3 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.3.1 Overview
        • 9.5.5.3.2 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.3.3 Rest of South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.3.3.1 Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
        • 9.5.5.3.4 Rest of South and Central America Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Liver Cancer Diagnostics Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Liver Cancer Diagnostics Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Liver Cancer Diagnostics Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 bioMerieux SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. HOFFMANN-LA ROCHE LTD.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Illumina, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Koninklijke Philips N.V.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Siemens Healthineers AG
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 THERMO FISHER SCIENTIFIC INC.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 GE Healthcare
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Perspectum
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Helio, Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 4. US Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 5. US Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada Liver Cancer Diagnostics Market, by Type-Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Mexico Liver Cancer Diagnostics Market, by Type -Revenue and Forecast to 2028 (USD Million)
  • Table 11. Mexico Liver Cancer Diagnostics Market, by Laboratory Tests -Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Europe Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 20280 (USD Million)
  • Table 14. Europe Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and forecast to 20280 (USD Million)
  • Table 15. Europe Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 16. Germany Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 17. Germany Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 18. Germany Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 19. UK Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 20. UK Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 21. UK Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 22. France Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 23. France Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 24. France Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 25. Spain Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 26. Spain Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 27. Spain Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 28. Italy Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 29. Italy Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 30. Italy Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 31. Rest of Europe: Liver Cancer Diagnostics Market, by Type- Revenue and forecast to 2028 (USD Million)
  • Table 32. Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
  • Table 33. Rest of Europe Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 34. Asia-Pacific Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 35. Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 36. Asia-Pacific Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 37. China Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 38. China Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 39. China Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 40. Japan Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 41. Japan Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
  • Table 42. Japan Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 43. India Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 44. India Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 45. India Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 46. South Korea Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 47. South Korea Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
  • Table 48. South Korea Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 49. Australia Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 50. Australia Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
  • Table 51. Australia Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 52. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 53. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 54. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
  • Table 55. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 56. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
  • Table 57. Middle East & Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 59. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
  • Table 60. UAE: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 62. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
  • Table 63. Saudi Arabia: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 65. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
  • Table 66. South Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 68. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
  • Table 69. Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
  • Table 71. South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 72. South and Central America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Brazil Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
  • Table 74. Brazil Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 75. Brazil Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Argentina Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
  • Table 77. Argentina Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 78. Argentina Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 79. Rest of South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
  • Table 80. Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
  • Table 81. Rest of South and Central America Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 82. Organic Developments in the Liver Cancer Diagnostics Market
  • Table 83. Inorganic Developments in the Liver Cancer Diagnostics Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Liver Cancer Diagnostics Market Segmentation
  • Figure 2. Liver Cancer Diagnostics Market Segmentation, By Region
  • Figure 3. Global Liver Cancer Diagnostics Market Overview
  • Figure 4. Laboratory Tests Segment Held Largest Share by Type in Liver Cancer Diagnostics Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Liver Cancer Diagnostics Market, By Geography (US$ Million)
  • Figure 7. Global Liver Cancer Diagnostics Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Liver Cancer Diagnostics Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis of Drivers and Restraint Pertaining to Liver Cancer Diagnostics Market
  • Figure 16. Global Liver Cancer Diagnostics Market - Revenue Forecast and Analysis - 2021- 2028
  • Figure 17. Global Liver Cancer Diagnostics Market - By Geography Forecast and Analysis - 2021- 2028.
  • Figure 18. Market Positioning of Key Players in Global Liver Cancer Diagnostics Market
  • Figure 19. Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
  • Figure 20. Laboratory Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Blood Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Biomarkers: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Endoscopy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Imaging: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Biopsy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Others: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
  • Figure 28. Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Academic and Research Institutes: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. CRO Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. North America: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 32. North America Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)
  • Figure 33. North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 34. US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 36. Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 37. Europe: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 38. Europe Liver Cancer Diagnostics Market Revenue and forecast to 2028 (USD Million)
  • Figure 39. Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 40. Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 41. UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 42. France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 43. Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 44. Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 45. Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
  • Figure 46. Asia-Pacific: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 47. Asia-Pacific Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 49. China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ MILLION)
  • Figure 50. Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Middle East & Africa Liver Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 56. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 60. South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 61. Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. South and Central America: Liver Cancer Diagnostics Market, By Key Country - Revenue (2021) (USD Million)
  • Figure 63. South and Central America: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 64. South and Central America: Liver Cancer Diagnostics Market Share by Country - 2021 & 2028, (%)
  • Figure 65. Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 66. Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
  • Figure 67. Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Countries
  • Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 72. Impact Of COVID-19 Pandemic in South and Central America Country Markets
  • Figure 73. Growth Strategies in the Liver Cancer Diagnostics Market (%)